Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2016

01-10-2016 | Original Article

Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia

Authors: Sarina Pasricha, Amit Gupta, Craig C. Reed, Olga Speck, John T. Woosley, Evan S. Dellon

Published in: Digestive Diseases and Sciences | Issue 10/2016

Login to get access

Abstract

Background

Lymphocytic esophagitis (LyE) is a recently described clinicopathological condition, but little is known about its features and clinical associations.

Aim

The aim of this study was to characterize patients with LyE, compare them to non-LyE controls, and identify risk factors.

Methods

We conducted a retrospective study of all patients ≥18 years old who underwent upper endoscopy with esophageal biopsy between January 1, 2000, and June 1, 2012. Archived pathology slides were re-reviewed, and LyE was diagnosed if there was lymphocyte-predominant esophageal inflammation with no eosinophils or granulocytes. Three non-LyE controls groups were also defined: reflux, eosinophilic esophagitis (EoE), and normal. Clinical data were extracted from electronic medical records, and LyE cases were compared to non-LyE controls.

Results

Twenty-seven adults were diagnosed with LyE, and the majority were female (63 %). The most common symptom was dysphagia (70 %). Fifty-two percentage had a prior or current diagnosis of reflux. Endoscopic findings included strictures (37 %), erosive esophagitis (33 %), rings (26 %), and hiatal hernia (26 %); 33 % of patients required dilation. After histology re-review, 78 % of LyE patients were found to have more than 20 lymphs/hpf. In comparison with the normal, reflux and EoE controls, patients with LyE tended to be nonwhite (p < 0.01), were more commonly tobacco users (p = 0.02) and less likely to have seasonal allergies (p = 0.02).

Conclusion

LyE commonly presents with dysphagia due to esophageal strictures which require dilation. Smoking was associated with LyE, whereas atopy was not. LyE should be considered as a diagnostic possibility in patients with these characteristics undergoing upper endoscopy.
Literature
1.
go back to reference Rubio CA, Sjodahl K, Lagergren J. Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol. 2006;125:432–437.CrossRefPubMed Rubio CA, Sjodahl K, Lagergren J. Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol. 2006;125:432–437.CrossRefPubMed
3.
go back to reference Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol. 2008;130:508–513.CrossRefPubMed Purdy JK, Appelman HD, Golembeski CP, McKenna BJ. Lymphocytic esophagitis: a chronic or recurring pattern of esophagitis resembling allergic contact dermatitis. Am J Clin Pathol. 2008;130:508–513.CrossRefPubMed
5.
go back to reference Haque S, Genta RM. Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut. 2012;61:1108–1114.CrossRefPubMed Haque S, Genta RM. Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut. 2012;61:1108–1114.CrossRefPubMed
6.
go back to reference Basseri B, Vasiliauskas EA, Chan O, et al. Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;9:505–511. Basseri B, Vasiliauskas EA, Chan O, et al. Evaluation of peripapillary lymphocytosis and lymphocytic esophagitis in adult inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;9:505–511.
7.
go back to reference Tanaka K, Rubio CA, Dlugosz A, et al. Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis. Gastrointest Endosc. 2013;78:659–664.CrossRefPubMed Tanaka K, Rubio CA, Dlugosz A, et al. Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis. Gastrointest Endosc. 2013;78:659–664.CrossRefPubMed
8.
go back to reference Lebwohl B, Green PH, Genta RM. Letter: lymphocytic gastritis and coeliac disease—authors’ reply. Aliment Pharmacol Ther. 2015;42:938.CrossRefPubMed Lebwohl B, Green PH, Genta RM. Letter: lymphocytic gastritis and coeliac disease—authors’ reply. Aliment Pharmacol Ther. 2015;42:938.CrossRefPubMed
9.
go back to reference Maejima R, Uno K, Iijima K, et al. A Japanese case of lymphocytic esophagitis. Dig Endosc. 2015. Maejima R, Uno K, Iijima K, et al. A Japanese case of lymphocytic esophagitis. Dig Endosc. 2015.
10.
go back to reference Ebach DR, Vanderheyden AD, Ellison JM, Jensen CS. Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn’s disease. Inflamm Bowel Dis. 2011;17:45–49.CrossRefPubMed Ebach DR, Vanderheyden AD, Ellison JM, Jensen CS. Lymphocytic esophagitis: a possible manifestation of pediatric upper gastrointestinal Crohn’s disease. Inflamm Bowel Dis. 2011;17:45–49.CrossRefPubMed
11.
go back to reference Ronkainen J, Walker MM, Aro P, et al. Lymphocytic oesophagitis, a condition in search of a disease? Gut. 2012;61:1776.CrossRefPubMed Ronkainen J, Walker MM, Aro P, et al. Lymphocytic oesophagitis, a condition in search of a disease? Gut. 2012;61:1776.CrossRefPubMed
12.
go back to reference Dellon ES, Gonsalves N, Hirano I et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692; quiz 693. Dellon ES, Gonsalves N, Hirano I et al. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108:679–692; quiz 693.
13.
go back to reference Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128:3–20.e26; quiz 21–22. Liacouras CA, Furuta GT, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011; 128:3–20.e26; quiz 21–22.
14.
go back to reference Hendy PJ, Wong DS, Florin TH. Spontaneous oesophageal perforation: an unreported complication of lymphocytic oesophagitis. Gut. 2013;62:1668–1669.CrossRefPubMed Hendy PJ, Wong DS, Florin TH. Spontaneous oesophageal perforation: an unreported complication of lymphocytic oesophagitis. Gut. 2013;62:1668–1669.CrossRefPubMed
15.
go back to reference Vangimalla S, Gordon I, Thota PN. Lymphocytic esophagitis in common variable immune deficiency. Am J Gastroenterol. 2016;111:170.CrossRefPubMed Vangimalla S, Gordon I, Thota PN. Lymphocytic esophagitis in common variable immune deficiency. Am J Gastroenterol. 2016;111:170.CrossRefPubMed
16.
go back to reference Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57:67–71.CrossRefPubMed Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES. Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr. 2013;57:67–71.CrossRefPubMed
17.
go back to reference Dunbar KB, Ayyar BKS, Spechler SJ, Genta RM, Melton SD. Clinical, endoscopic and histological features of patients with lymphocytic esophagitis compared to patients with GERD. Gastroenterology. 2014;5085:Mo 1846. Abstract. Dunbar KB, Ayyar BKS, Spechler SJ, Genta RM, Melton SD. Clinical, endoscopic and histological features of patients with lymphocytic esophagitis compared to patients with GERD. Gastroenterology. 2014;5085:Mo 1846. Abstract.
18.
go back to reference Basseri B, Levy M, Wang HL, et al. Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis. Dis Esophagus. 2010;23:368–376.PubMed Basseri B, Levy M, Wang HL, et al. Redefining the role of lymphocytes in gastroesophageal reflux disease and eosinophilic esophagitis. Dis Esophagus. 2010;23:368–376.PubMed
19.
go back to reference Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275–285.CrossRefPubMed Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol. 2005;40:275–285.CrossRefPubMed
20.
go back to reference Sutton LM, Heintz DD, Patel AS, Weinberg AG. Lymphocytic esophagitis in children. Inflamm Bowel Dis. 2014;20:1324–1328.CrossRefPubMed Sutton LM, Heintz DD, Patel AS, Weinberg AG. Lymphocytic esophagitis in children. Inflamm Bowel Dis. 2014;20:1324–1328.CrossRefPubMed
Metadata
Title
Lymphocytic Esophagitis: An Emerging Clinicopathologic Disease Associated with Dysphagia
Authors
Sarina Pasricha
Amit Gupta
Craig C. Reed
Olga Speck
John T. Woosley
Evan S. Dellon
Publication date
01-10-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4230-2

Other articles of this Issue 10/2016

Digestive Diseases and Sciences 10/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine